Tumor Burden Is Not Associated with Efficacy of Immune Checkpoint Inhibitors in Advanced Lung Cancer

被引：0
|
作者：
Gerber, D. [1 ]
Popat, V. [1 ]
Lu, R. [1 ]
Saltarski, J. [1 ]
Gloria-Mccutchen, Y. [1 ]
Fattah, F. [1 ]
Park, J. [1 ]
Xie, Y. [1 ]
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Computed tomography; Lung cancer; Immunotherapy;
D O I：
10.1016/j.jtho.2019.08.974
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.04-71
引用
收藏
页码：S469 / S469
页数：1
相关论文
共 50 条
  • [31] Immune checkpoint inhibitors in advanced non-small cell lung cancer
    Fabre, Elizabeth
    Pecuchet, Nicola
    Cadranel, Jacques
    BULLETIN DU CANCER, 2016, 103 : S138 - S143
  • [32] Discussion of tumor mutation burden as an indicator to predict efficacy of immune checkpoint inhibitors: A case report
    Wu, Mingrui
    Liang, Lan
    Dai, Xiaotian
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [33] Correlation of lung immune prognostic index with the efficacy of immune checkpoint inhibitors in Chinese patients with advanced non-small cell lung cancer
    Xiaoyu Zhi
    Zhibo Zhang
    Weiwei Li
    Zhouhuan Dong
    Xiaodong Wu
    Xiangwei Ge
    Jinzhao Zhai
    Di Lu
    Xiang Yan
    Jinliang Wang
    Holistic Integrative Oncology, 3 (1):
  • [34] The value and inadequacy of tumor mutation burden on efficacy of immune checkpoint inhibitors in head and neck cancers
    Ma, Hui-hui
    Chen, Dong-sheng
    Li, Si
    Xiao, Ming-zhe
    Qi, Chuang
    ORAL ONCOLOGY, 2021, 117
  • [35] Tumor Mutational Burden and Efficacy of Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
    Kim, Jong Yeob
    Kronbichler, Andreas
    Eisenhut, Michael
    Hong, Sung Hwi
    van der Vliet, Hans J.
    Kang, Jeonghyun
    Shin, Jae Il
    Gamerith, Gabriele
    CANCERS, 2019, 11 (11)
  • [36] Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer
    Assi, Hazem I.
    Kamphorst, Alice O.
    Moukalled, Nour M.
    Ramalingam, Suresh S.
    CANCER, 2018, 124 (02) : 248 - 261
  • [37] A Network Comparison on Safety Profiling of Immune Checkpoint Inhibitors in Advanced Lung Cancer
    Yan, Yi-Dan
    Cui, Jiu-Jie
    Fu, Jie
    Su, Ying-Jie
    Chen, Xiao-Yu
    Gu, Zhi-Chun
    Lin, Hou-Wen
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [38] Clinical predictive factors of the efficacy of immune checkpoint inhibitors and kinase inhibitors in advanced hepatocellular cancer
    Lu, Yunyun
    Lu, Yi
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2025, 27 (03): : 1142 - 1154
  • [39] THE SUM OF TUMOR SIZE PREDICTS THE EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN NON-SMALL CELL LUNG CANCER
    Shiraishi, Yusuke
    Marumo, Satoshi
    Amimoto, Hisanori
    Yamaki, Haruka
    Shirata, Masahiro
    Imoto, Takamitsu
    Kitajima, Takamasa
    Inoue, Daiki
    Katayama, Yuko
    Fukui, Motonari
    RESPIROLOGY, 2018, 23 : 289 - 289
  • [40] Impact of opioid analgesics on the efficacy of immune checkpoint inhibitors in a lung cancer population
    Yu, Xiaoyuan
    Zhao, Li
    Song, Bin
    BMC PULMONARY MEDICINE, 2022, 22 (01)
12345